W.Va. Ax Of Biogen MS Drug Patent Binds Del. Litigation
A Delaware federal judge on Wednesday said she's bound by a June decision from West Virginia invalidating a patent covering Biogen's blockbuster multiple sclerosis drug Tecfidera, even though she presided over...To view the full article, register now.
Already a subscriber? Click here to view full article